REFERENCES ADDED TO GINA 2015

Apter AJ, Wan F, Reisine S, et al. The association of health literacy with adherence and outcomes in
moderate-severe asthma. J Allergy Clin Immunol. 2013;132:321-327
Chauhan BF, Ducharme FM. Addition to inhaled corticosteroids of long-acting beta2-agonists versus
anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev. 2014;1:CD003137. (replacing
earlier Cochrane review, reference 164)
Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short-acting beta2-agonists for
initial treatment of acute asthma in children. Cochrane Database Syst Rev. 2013;8:CD000060
Keeney GE, Gray MP, Morrison AK, et al. Dexamethasone for acute asthma exacerbations in children:
a meta-analysis. Pediatrics. 2014;133:493-499. (replacing previous reference 336 Kravitz et al
2011)
Kerstjens HA et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a
randomized controlled trial. J Allergy Clin Immunol. 2011;128:308-314.
Kew KM, Karner C, Mindus SM, et al. Combination formoterol and budesonide as maintenance and
reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
Cochrane Database Syst Rev. 2013;12:CD009019
Lim AS, Stewart K, Abramson MJ, et al. Multidisciplinary Approach to Management of Maternal
Asthma (MAMMA): a randomized controlled trial. Chest. 2014;145:1046-1054
Murphy VE, Powell H, Wark PA, et al. A prospective study of respiratory viral infection in pregnant
women with and without asthma. Chest. 2013;144:420-427.
Nelson-Piercy C. Asthma in pregnancy. Thorax. 2001;56:325-328.
Nguyen JM, Holbrook JT, Wei CY, et al. Validation and psychometric properties of the Asthma Control
Questionnaire among children. J Allergy Clin Immunol. 2014;133:91-97.e91-96.
Normansell R, Walker S, Milan SJ, et al. Omalizumab for asthma in adults and children. Cochrane
Database Syst Rev. 2014;1:CD003559. (replacing previous reference 174, Rodrigo et al, Chest
2011)
Nuijsink M, Hop WC, Jongste JC, et al. Perception of bronchoconstriction: a complementary disease
marker in children with asthma. J Asthma. 2013;50:560-564.
Patel M, Pilcher J, Reddel HK, et al. Metrics of salbutamol use as predictors of future adverse
outcomes in asthma. Clin Exp Allergy. 2013;43:1144-1151.
Peters SP et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J
Med. 2010;363:1715-1726.
Rodrigo GJ, Castro-Rodriguez JA. Heliox-driven beta2-agonists nebulization for children and adults
with acute asthma: a systematic review with meta-analysis. Ann Allergy Asthma Immunol.
2014;112:29-34. (replacing previous reference 336 Colebourne et al 2007).
Selroos O. Dry-powder inhalers in acute asthma. Ther Deliv. 2014;5:69-81.
Travers J, et al. External validity of randomised controlled trials in asthma: to whom do the results of
the trials apply? Thorax. 2007;62:219-223.
Travers J, et al. External validity of randomized controlled trials in COPD. Respir Med. 2007;101:13131320.
The following references were omitted in error from the 2014 report and have been restored
Bisgaard H. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children. Pediatr
Pulmonol. 2003;36:391-398.
Vaessen-Verberne AA, van den Berg NJ, van Nierop JC, et al. Combination therapy
salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. Am J Respir Crit
Care Med. 2010;182:1221-1227.